Rein Therapeutics Inc Share Price Today: Live Updates & Key Insights
Rein Therapeutics Inc share price today is $1.23, up -4.62%. The stock opened at $1.3 against the previous close of $1.3, with an intraday high of $1.3 and low of $1.2.
Rein Therapeutics Inc Share Price Chart
Rein Therapeutics Inc
Rein Therapeutics Inc Share Price Performance
Rein Therapeutics Inc Institutional Holdings
Rein Therapeutics Inc Market Status
Rein Therapeutics Inc Fundamentals
Market Cap 32.60 M
PB Ratio 29.5029
PE Ratio 0.0
Enterprise Value 16.91 M
Total Assets 69.24 M
Volume 184562
Rein Therapeutics Inc Company Financials
About Rein Therapeutics Inc & investment objective
Company Information Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). It also offers LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications; and LTI-05, an epithelial sodium channel for the treatment of cystic fibrosis. The company was formerly known as Aileron Therapeutics, Inc. and changed its name to Rein Therapeutics Inc. in February 2007. The company was incorporated in 2001 and is headquartered in Austin, Texas.
Organisation Biotechnology
Employees 11
Industry Biotechnology
CEO Dr. James Brian Windsor Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Rein Therapeutics Inc FAQs
What is the share price of Rein Therapeutics Inc today?
The current share price of Rein Therapeutics Inc is $1.23.
Can I buy Rein Therapeutics Inc shares in India?
Yes, Indian investors can buy Rein Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Rein Therapeutics Inc shares in India?
You can easily invest in Rein Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Rein Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Rein Therapeutics Inc.
Can I buy fractional shares of Rein Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Rein Therapeutics Inc?
Rein Therapeutics Inc has a market cap of $32.60 M.
In which sector does Rein Therapeutics Inc belong?
Rein Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Rein Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Rein Therapeutics Inc?
The PE ratio of Rein Therapeutics Inc is N/A and the PB ratio is 29.50.